Incobotulinumtoxina Intramuscular and Moxetumomab Pasudotox-tdfk
Determining the interaction of Incobotulinumtoxina Intramuscular and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: incobotulinumtoxinA
Brand name: Xeomin
Synonyms: Incobotulinumtoxina (Intramuscular)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Incobotulinumtoxina Intramuscular-Moxetumomab pasudotox-tdfk Intravenous
- Incobotulinumtoxina Intramuscular-Moxifloxacin
- Incobotulinumtoxina Intramuscular-Moxifloxacin (Systemic)
- Incobotulinumtoxina Intramuscular-Moxifloxacin Hydrochloride
- Incobotulinumtoxina Intramuscular-Moxifloxacin Injection
- Incobotulinumtoxina Intramuscular-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Increlex
- Moxetumomab Pasudotox-tdfk-Incruse Ellipta
- Moxetumomab Pasudotox-tdfk-Indacaterol
- Moxetumomab Pasudotox-tdfk-Indacaterol and Glycopyrrolate
- Moxetumomab Pasudotox-tdfk-Indacaterol and glycopyrrolate Inhalation
- Moxetumomab Pasudotox-tdfk-Indacaterol inhalation